Leadership

Daiichi Sankyo, Head of Data Governance, R&D: Significance of Data in Drug Development Life Cycle2

avatar

Written by: CDO Magazine Bureau

Updated 8:50 AM UTC, Mon November 27, 2023

post detail image

(USA and Canada) Hayes Williams, Head of Data Governance, R&D at Daiichi Sankyo, together with Baz Khuti, President US at Modak, explains the importance of data in his role as a CDO. Williams’ responsibilities in research and development are fully invested in data. From the beginning of basic research to managing clinical trials, quality data management and governance are essential across the company. The overall life cycle of drug development highlights data as a strategic asset in providing the best drug treatments for patients.

Related Stories

July 16, 2025  |  In Person

Boston Leadership Dinner

Glass House

Similar Topics
AI News Bureau
Data Management
Diversity
Testimonials
background image
Community Network

Join Our Community

starStay updated on the latest trends

starGain inspiration from like-minded peers

starBuild lasting connections with global leaders

logo
Social media icon
Social media icon
Social media icon
Social media icon
About